| Ryan Christopher Meis, MD | |
|
575 N Sioux Point Rd, Dakota Dunes, SD 57049-5312 | |
| (605) 217-2667 | |
| (605) 217-2900 |
| Full Name | Ryan Christopher Meis |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 25 Years |
| Location | 575 N Sioux Point Rd, Dakota Dunes, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053314385 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 5591 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dunes Surgical Hospital | Dakota dunes, SD | Hospital |
| Cherokee Regional Medical Center | Cherokee, IA | Hospital |
| Floyd Valley Healthcare | Le mars, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cnos Pc | 4284548942 | 102 |
| Cnos Pc | 4284548942 | 102 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the fourth quarter and fiscal year ended December 31, 2009.
In a new survey, Harvard School of Public Health (HSPH) researchers found that just 40% of adults are "absolutely certain" they will get the H1N1 vaccine for themselves, and 51% of parents are "absolutely certain" that they will get the vaccine for their children. The survey examined the reasoning among those who said they would not get the vaccine or might not. This is the latest in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program at HSPH. The polling was done September 14-20, 2009.
Synthon has announced that its subsidiary Synthon Pharmaceuticals, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for tadalafil tablets, 20 mg on April 13, 2012. Synthon's product is a generic and bioequivalent version of Eli Lilly & Co and United Therapeutics' Adcirca® tablets, which are indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.
Cases of major depressive disorder and anxiety disorders increased by more than a quarter worldwide in 2020 due to the COVID-19 pandemic, according to the first global estimates of impacts of the pandemic on mental health, published in The Lancet.
› Verified 7 days ago
| Entity Name | Cnos Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881604320 PECOS PAC ID: 4284548942 Enrollment ID: O20031217000907 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the fourth quarter and fiscal year ended December 31, 2009.
In a new survey, Harvard School of Public Health (HSPH) researchers found that just 40% of adults are "absolutely certain" they will get the H1N1 vaccine for themselves, and 51% of parents are "absolutely certain" that they will get the vaccine for their children. The survey examined the reasoning among those who said they would not get the vaccine or might not. This is the latest in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program at HSPH. The polling was done September 14-20, 2009.
Synthon has announced that its subsidiary Synthon Pharmaceuticals, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for tadalafil tablets, 20 mg on April 13, 2012. Synthon's product is a generic and bioequivalent version of Eli Lilly & Co and United Therapeutics' Adcirca® tablets, which are indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.
Cases of major depressive disorder and anxiety disorders increased by more than a quarter worldwide in 2020 due to the COVID-19 pandemic, according to the first global estimates of impacts of the pandemic on mental health, published in The Lancet.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Christopher Meis, MD 575 N Sioux Point Rd, Dakota Dunes, SD 57049-5312 Ph: (605) 217-2667 | Ryan Christopher Meis, MD 575 N Sioux Point Rd, Dakota Dunes, SD 57049-5312 Ph: (605) 217-2667 |
News Archive
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the fourth quarter and fiscal year ended December 31, 2009.
In a new survey, Harvard School of Public Health (HSPH) researchers found that just 40% of adults are "absolutely certain" they will get the H1N1 vaccine for themselves, and 51% of parents are "absolutely certain" that they will get the vaccine for their children. The survey examined the reasoning among those who said they would not get the vaccine or might not. This is the latest in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program at HSPH. The polling was done September 14-20, 2009.
Synthon has announced that its subsidiary Synthon Pharmaceuticals, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for tadalafil tablets, 20 mg on April 13, 2012. Synthon's product is a generic and bioequivalent version of Eli Lilly & Co and United Therapeutics' Adcirca® tablets, which are indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.
Cases of major depressive disorder and anxiety disorders increased by more than a quarter worldwide in 2020 due to the COVID-19 pandemic, according to the first global estimates of impacts of the pandemic on mental health, published in The Lancet.
› Verified 7 days ago
Joshua Hockett, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 052-172-6676 Fax: 605-217-2900 | |
Thomas Paul Jacobson, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 | |
Dr. Benjamin T. Bissell, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 575 Sioux Point Road, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 | |
Gordon Allan Porter, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2615 Fax: 605-217-2915 | |
Dr. Brian Douglas Johnson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 | |
Mr. Raymond Michael Sherman, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 |